S100β induces neuronal cell death through nitric oxide release from astrocytes

Journal of Neurochemistry

Volumn 69, Issue 6, 1997, Pages 2294-2301

  Hu, Jingru ^a   Ferreira, Adriana ^a,b   Van Eldik, Linda J ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Northwestern Drug Discovery Program   (United States)

Author keywords

Apoptosis; Astrocyte; Neurotoxicity; Nitric oxide; Programmed cell death; S100

Indexed keywords

NITRIC OXIDE; PROTEIN S 100; CALCIUM BINDING PROTEIN; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; HIPPOCAMPUS; HUMAN; NERVE DEGENERATION; NEUROBLASTOMA; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; ANIMAL; CATTLE; CELL SURVIVAL; COCULTURE; DRUG EFFECT; ENZYME INDUCTION; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALIA;

ANIMALS; APOPTOSIS; ASTROCYTES; CALCIUM-BINDING PROTEINS; CATTLE; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME INDUCTION; NERVE GROWTH FACTORS; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; S100 PROTEINS;

EID: 0030613810     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69062294.x     Document Type: Article

References (33)

1. Andrew P. J., Harant H., and Lindley I. J. D. (1995) Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214, 949-956.
2. Barger S. W. and Van Eldik L. J. (1992) S100β stimulates calcium fluxes in glial and neuronal cells. J. Biol. Chem. 267, 9689-9694.
3. Barger S. W., Wolchok S. R., and Van Eldik L. J. (1992) Disulfide-linked S100β dimers and signal transduction. Biochim. Biophys. Acta 1160, 105-112.
4. Bottenstein J. E. and Sato G. H. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76, 514-517.
5. Chao C. C., Hu S., Molitor T. W., Shaskan E. G., and Peterson P. K. (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
6. Chao C. C., Hu S., Sheng W. S., Bu D., Bukrinsky M. I., and Peterson P. K. (1996) Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16, 276-284.
7. Dawson V. L. (1995) Nitric oxide: role in neurotoxicity. Clin. Exp. Pharmacol. Physiol. 22, 305-308.
8. Fujihara M., Ito N., Pace J. L., Watanabe Y., Russell S. W., and Suzuki T. (1994) Role of endogenous interferon-β in lipopolysaccharide-triggered activation of the inducible nitric oxide synthase gene in a mouse macrophage cell line, J774. J. Biol. Chem. 269, 12773-12778.
9. Goslin K. and Banker G. A. (1991) Rat hippocampal neurons in low-density culture, in Culturing Nerve Cells (Banker G. A. and Goslin K., eds), pp. 251-281. MIT Press, Cambridge.
10. Griffin W. S. T. and Stanley L. C. (1993) Glial activation as a common denominator in neurodegenerative disease: a hypothesis in neuropathophysiology, in Biology and Pathology of Astrocytes-Neuron Interactions (Federoff S., Juurlink B. H. J., Doucette R., and Burkholder G., eds), pp. 359-381. Plenum Press, New York.
11. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L., and Araoz C. (1989) Brain interleukin 1 and S100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
12. 1-42 peptide is cell type dependent. J. Neurochem. 65, 292-300.
13. Hale A. J., Smith C. A., Sutherland L. C., Stoneman V. E. A., Long-thorne V.L., Culhane A.C., and Williams G. T. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236, 1-26.
14. Hewett S. J., Csernansky C. A., and Choi D. W. (1994) Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13, 487-494.
15. Hu J. and Van Eldik L. J. (1996) S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta 1313, 239-245.
16. Hu J., Castets F., Guevara J. L., and Van Eldik L. J. (1996) S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271, 2543-2547.
17. Jorgensen O. S., Brooksbank B. W. L., and Balazs R. (1990) Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer's disease. J. Neurol. Sci. 98, 63-79.
18. Kato K., Suzuki F., Morishita R., Asano T., and Sato T. (1990) Selective increase in S100β protein by aging in rat cerebral cortex. J. Neurochem. 54, 1269-1274.
19. Linnemann D. and Skarsfelt T. (1994) Regional changes in expression of NCAM, GFAP, and S100 in aging rat brain. Neurobiol. Aging 15, 651-655.
20. Mann D. M. A. (1988) The pathologic association between Down syndrome and Alzheimer disease. Mech. Ageing Dev. 43, 99-136.
21. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villaba M., Ferrari D., and Rossi F. (1995) Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650.
22. Mitrovic B., Ignarro L. J., Montestruque S., Smoll A., and Merrill J. E. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61, 575-585.
23. Moncada S., Palmer R. M. J., and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
24. Mrak R. E., Sheng J. G., and Griffin W. S. T. (1995) Glial cytokines in Alzheimer's disease. Review and pathogenic implications. Hum. Pathol. 26, 816-823.
25. Mrak R. E., Sheng J. G., and Griffin W. S. T. (1996) Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 273-279.
26. Murphy S. and Grzybicki D. (1996) Glial NO: normal and pathological roles. Neuroscientist 2, 90-99.
27. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Patrick J., Steinbach J. H., Culp W., and Brandt B. L. (1974) Clonal cell lines from the rat central nervous system. Nature 249, 224-227.
28. Sheng J. G., Mark R. E., and Griffin W. S. T. (1994) S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39, 398-404.
29. Sheng J. G., Mrak R. E., Rovnaghi C. R., Kozlowska E., Van Eldik L. J., and Griffin W. S. T. (1996) Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging 17, 359-363.
30. Van Dervort A. L., Van L., Madara P. J., Cobb J. P., Wesley R. A., Corriveau C. C., Tropea M. M., and Danner R. L. (1994) Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils. J. Immunol. 152, 4102-4109.
31. Van Eldik L. J. and Griffin W. S. T. (1994) S100β expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta 1223, 398-403.
32. Van Eldik L. J., Staecker J. L., and Winningham-Major F. (1988) Synthesis and expression of a gene coding for the calcium-modulated protein S100β and designed for cassette-based, site-directed mutagenesis. J. Biol. Chem. 263, 7830-7837.
33. Wisniewski K. E., Wisniewski H. M., and Wen G. Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282.